Olivier L Chinot Selected Research

Angiogenesis Inhibitors

1/2022

Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier L Chinot Research Topics

Disease

23	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2003
13	Neoplasms (Cancer) 04/2024 - 04/2007
6	Glioma (Gliomas) 01/2022 - 05/2013
3	Astrocytoma (Pilocytic Astrocytoma) 12/2023 - 01/2021
3	Disease Progression 01/2017 - 12/2003
2	Hemorrhage 01/2018 - 01/2016
1	Central Nervous System Neoplasms 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2020
1	Colorectal Neoplasms (Colorectal Cancer) 06/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020
1	Breast Neoplasms (Breast Cancer) 06/2020
1	Ovarian Neoplasms (Ovarian Cancer) 06/2020
1	Hepatocellular Carcinoma (Hepatoma) 06/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2020
1	Carcinogenesis 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Cerebral Hemorrhage 01/2016
1	Alopecia (Baldness) 01/2016
1	Abscess 01/2016
1	Stroke (Strokes) 01/2016
1	Dysphonia (Spastic Dysphonia) 07/2015
1	Hypertension (High Blood Pressure) 07/2015
1	Headache (Headaches) 07/2015
1	Fatigue 07/2015
1	Body Weight (Weight, Body) 02/2014
1	Brain Neoplasms (Brain Tumor) 12/2003

Drug/Important Bio-Agent (IBA)

18	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 12/2003
17	Bevacizumab (Avastin)FDA Link 01/2022 - 11/2012
3	MethyltransferasesIBA 01/2019 - 04/2007
2	SteamIBA 04/2024 - 12/2023
2	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 04/2024 - 12/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Monoclonal AntibodiesIBA 07/2015 - 11/2012
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023
1	Alkylating AgentsIBA 12/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	ChromatinIBA 01/2019
1	O-(6)-methylguanineIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	AnticoagulantsIBA 01/2018
1	vasectrin IIIIBA 01/2018
1	onartuzumabIBA 01/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2017
1	LigandsIBA 01/2017
1	TB-403IBA 07/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2015
1	CilengitideIBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013

Therapy/Procedure

14	Radiotherapy 01/2022 - 12/2003
10	Therapeutics 06/2020 - 12/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
1	Conformal Radiotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Immunotherapy 06/2020
1	Chemoradiotherapy 01/2018